Literature DB >> 20460375

Loss of cystic fibrosis transmembrane conductance regulator function enhances activation of p38 and ERK MAPKs, increasing interleukin-6 synthesis in airway epithelial cells exposed to Pseudomonas aeruginosa.

Julie Bérubé1, Lucie Roussel, Leila Nattagh, Simon Rousseau.   

Abstract

In cystic fibrosis (CF), the absence of functional cystic fibrosis transmembrane conductance regulator (CFTR) translates into chronic bacterial infection, excessive inflammation, tissue damage, impaired lung function and eventual death. Understanding the mechanisms underlying this vicious circle of inflammation is important to design better therapies for CF. We found in CF lung biopsies increased immunoreactivity for p38 MAPK activity markers. Moreover, when compared with their non-CF counterpart, airway epithelial cells expressing the most common mutation in CF (CFTRDeltaF508) were more potent at inducing neutrophil chemotaxis through increased interleukin (IL)-6 synthesis when challenged with Pseudomonas aeruginosa diffusible material. We then discovered that in CFTRDeltaF508 cells, the p38 and ERK MAPKs are hyperactivated in response to P. aeruginosa diffusible material, leading to increased IL-6 mRNA expression and stability. Moreover, although TLR5 contributes to p38 MAPK activation upon P. aeruginosa challenge, it only played a weak role in IL-6 synthesis. Instead, we found that the production of reactive oxygen species is essential for IL-6 synthesis in response to P. aeruginosa diffusible material. Finally, we uncovered that in CFTRDeltaF508 cells, the extracellular glutathione levels are decreased, leading to a greater sensitivity to reactive oxygen species, providing an explanation for the hyperactivation of the p38 and ERK MAPKs and increased IL-6 synthesis. Taken together, our study has characterized a mechanism whereby the CFTRDeltaF508 mutation in airway epithelial cells contributes to increase inflammation of the airways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20460375      PMCID: PMC2903409          DOI: 10.1074/jbc.M109.098566

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Cystic fibrosis pathogens activate Ca2+-dependent mitogen-activated protein kinase signaling pathways in airway epithelial cells.

Authors:  A J Ratner; R Bryan; A Weber; S Nguyen; D Barnes; A Pitt; S Gelber; A Cheung; A Prince
Journal:  J Biol Chem       Date:  2001-03-08       Impact factor: 5.157

Review 3.  How Toll-like receptors signal: what we know and what we don't know.

Authors:  Luke A J O'Neill
Journal:  Curr Opin Immunol       Date:  2005-12-15       Impact factor: 7.486

4.  Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines.

Authors:  D Kube; U Sontich; D Fletcher; P B Davis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-03       Impact factor: 5.464

5.  Dysregulated cytokine production in human cystic fibrosis bronchial epithelial cells.

Authors:  A A Stecenko; G King; K Torii; R M Breyer; R Dworski; T S Blackwell; J W Christman; K L Brigham
Journal:  Inflammation       Date:  2001-06       Impact factor: 4.092

6.  MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels.

Authors:  Armin Neininger; Dimitris Kontoyiannis; Alexey Kotlyarov; Reinhard Winzen; Rolf Eckert; Hans-Dieter Volk; Helmut Holtmann; George Kollias; Matthias Gaestel
Journal:  J Biol Chem       Date:  2001-12-06       Impact factor: 5.157

7.  Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs.

Authors:  Simon Rousseau; Nick Morrice; Mark Peggie; David G Campbell; Matthias Gaestel; Philip Cohen
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

Review 8.  Oxidative stress and gene regulation.

Authors:  R G Allen; M Tresini
Journal:  Free Radic Biol Med       Date:  2000-02-01       Impact factor: 7.376

Review 9.  Lung infections associated with cystic fibrosis.

Authors:  Jeffrey B Lyczak; Carolyn L Cannon; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

Review 10.  Exacerbations: etiology and pathophysiologic mechanisms.

Authors:  Jadwiga A Wedzicha
Journal:  Chest       Date:  2002-05       Impact factor: 9.410

View more
  30 in total

1.  Down-regulation of IL-8 by high-dose vitamin D is specific to hyperinflammatory macrophages and involves mechanisms beyond up-regulation of DUSP1.

Authors:  N Dauletbaev; K Herscovitch; M Das; H Chen; J Bernier; E Matouk; J Bérubé; S Rousseau; L C Lands
Journal:  Br J Pharmacol       Date:  2015-10       Impact factor: 8.739

2.  Baicalin Inhibits Lipopolysaccharide-Induced Inflammation Through Signaling NF-κB Pathway in HBE16 Airway Epithelial Cells.

Authors:  Shou-jin Dong; Yun-qing Zhong; Wen-ting Lu; Guan-hong Li; Hong-li Jiang; Bing Mao
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

Review 3.  The role of stretch-activated ion channels in acute respiratory distress syndrome: finally a new target?

Authors:  Andreas Schwingshackl
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-08-12       Impact factor: 5.464

4.  Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis.

Authors:  Qingdong Guan; Yanbing Ma; China-Li Hillman; Gefei Qing; Allan G Ma; Carolyn R Weiss; Gang Zhou; Aiping Bai; Richard J Warrington; Charles N Bernstein; Zhikang Peng
Journal:  Mol Med       Date:  2011-03-11       Impact factor: 6.354

5.  Heterozygosity for the F508del mutation in the cystic fibrosis transmembrane conductance regulator anion channel attenuates influenza severity.

Authors:  Famke Aeffner; Basant Abdulrahman; Judy M Hickman-Davis; Paul M Janssen; Amal Amer; David M Bedwell; Eric J Sorscher; Ian C Davis
Journal:  J Infect Dis       Date:  2013-06-07       Impact factor: 5.226

6.  Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.

Authors:  Timothy J Bensman; Jordanna G Jayne; Meiling Sun; Elza Kimura; Joshua Meinert; Joshua C Wang; Justin B Schaal; Dat Tran; Adupa P Rao; Omid Akbari; Michael E Selsted; Paul M Beringer
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

Review 7.  Cystic fibrosis: a mucosal immunodeficiency syndrome.

Authors:  Taylor Sitarik Cohen; Alice Prince
Journal:  Nat Med       Date:  2012-04-05       Impact factor: 53.440

Review 8.  Dysregulated Chemokine Signaling in Cystic Fibrosis Lung Disease: A Potential Therapeutic Target.

Authors:  Xiaoqing Guan; Yuning Hou; Fei Sun; Zhe Yang; Chunying Li
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

9.  Unravelling druggable signalling networks that control F508del-CFTR proteostasis.

Authors:  Ramanath Narayana Hegde; Seetharaman Parashuraman; Francesco Iorio; Fabiana Ciciriello; Fabrizio Capuani; Annamaria Carissimo; Diego Carrella; Vincenzo Belcastro; Advait Subramanian; Laura Bounti; Maria Persico; Graeme Carlile; Luis Galietta; David Y Thomas; Diego Di Bernardo; Alberto Luini
Journal:  Elife       Date:  2015-12-23       Impact factor: 8.140

10.  Impairment in inflammasome signaling by the chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients results in an increase in inflammatory response.

Authors:  Melissa S Phuong; Rafael E Hernandez; Daniel J Wolter; Lucas R Hoffman; Subash Sad
Journal:  Cell Death Dis       Date:  2021-03-04       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.